Wednesday, January 25, 2023
Lupin Digital Health, a wholly-owned subsidiary of global pharma major Lupin, announced the launch of its digital therapeutics solution, LYFE.
LYFE helps patients in improving their heart health through doctor-connected online and offline modules. LYFE’s simple and intuitive interface offers medication reminders, 24X7 emergency and ambulance assistance. Moreover, LYFE offers expert intervention in the form of dedicated care managers, health coaches and nutritionists. LYFE is an end-to-end solution for cardiac patients, in accordance with protocols designed by their treating cardiologists.
Designed with leading cardiologist’s inputs, LYFE improves the quality of life of patients and reduces the stress and anxiety of their caregiver.
Patients with chronic cardiovascular diseases experience higher uncertainty and require significant care and monitoring. With LYFE, a digital therapy platform, enables the power of human intelligence and AI/ML to improve patient outcomes by enhancing physician-patient collaboration, continuously monitoring health factors, increasing patient awareness and improving adherence.
